academia

Wien (OTS) - The pool of patients suffering from an individual rare disease is very small. Drug development in this area is complex and the risk of failure is much higher than for other diseases. Basic research and the search for…
Weiterlesen...

Wien (OTS) - The pool of patients suffering from an individual rare disease is very small. Drug development in this area is complex and the risk of failure is much higher than for other diseases. Basic research and the search for…
Weiterlesen...

London (ots/PRNewswire) - Two-week educational event opens to the public (15-27th September) in White City, with free tickets available at BlueParadox.com SC Johnson, the maker of household consumer brands such as Mr Muscle®, Ecover®…
Weiterlesen...

Bengaluru, India (ots/PRNewswire) - Infosys Living Labs is delivering digital innovation as-a-service to help them meet next normal consumer expectations Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation…
Weiterlesen...

Darmstadt, Germany (ots/PRNewswire) - - Merck to support up to six additional research projects at the BioMed X Institute in Heidelberg within the next six years - Call for application for a global crowdsourcing project, 'Regulatory T…
Weiterlesen...

London (ots/PRNewswire) - Infosys (NYSE: INFY), a global leader in next-generation digital services and consulting, has partnered with the Ellen MacArthur Foundation charity. The organisations will work together to accelerate the…
Weiterlesen...

Riyadh, Saudi Arabia (ots/PRNewswire) - The G20 has a strong tradition of working with a broad range of organizations to bring different perspectives on socioeconomic challenges to the G20 table. The Engagement Groups are independent…
Weiterlesen...

Bengaluru, India (ots/PRNewswire) - - Offers over 14,000 cloud assets and over 200 industry cloud solution blueprints Infosys (NYSE: INFY), a global leader in next-generation digital services and consulting, today launched Infosys…
Weiterlesen...